These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3532121)

  • 1. "Replacement" of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential.
    Browning PJ; Bunn HF; Cline A; Shuman M; Nienhuis AW
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7800-4. PubMed ID: 3532121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.
    Wheeler EF; Roussel MF; Hampe A; Walker MH; Fried VA; Look AT; Rettenmier CW; Sherr CJ
    J Virol; 1986 Aug; 59(2):224-33. PubMed ID: 3525854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming mechanism of the feline sarcoma virus encoded v-fms oncogene product.
    Tamura T; Hadwiger-Fangmeier A; Simon E; Smola U; Geschwill H; Schütz B; Trouliaris S; Boscheck B; Niemann H; Bauer H
    Behring Inst Mitt; 1991 Jul; (89):93-9. PubMed ID: 1834054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
    Roussel MF; Dull TJ; Rettenmier CW; Ralph P; Ullrich A; Sherr CJ
    Nature; 1987 Feb 5-11; 325(6104):549-52. PubMed ID: 3027579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms.
    Mancini A; Koch A; Wilms R; Tamura T
    J Biol Chem; 2002 Apr; 277(17):14635-40. PubMed ID: 11847211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fms gene and the CSF-1 receptor.
    Sherr CJ; Rettenmier CW
    Cancer Surv; 1986; 5(2):221-32. PubMed ID: 3022923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain.
    Roussel MF; Downing JR; Ashmun RA; Rettenmier CW; Sherr CJ
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):5903-7. PubMed ID: 2842754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.
    Coussens L; Van Beveren C; Smith D; Chen E; Mitchell RL; Isacke CM; Verma IM; Ullrich A
    Nature; 1986 Mar 20-26; 320(6059):277-80. PubMed ID: 2421165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new acute transforming feline retrovirus with fms homology specifies a C-terminally truncated version of the c-fms protein that is different from SM-feline sarcoma virus v-fms protein.
    Besmer P; Lader E; George PC; Bergold PJ; Qiu FH; Zuckerman EE; Hardy WD
    J Virol; 1986 Oct; 60(1):194-203. PubMed ID: 3018286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line.
    Wheeler EF; Rettenmier CW; Look AT; Sherr CJ
    Nature; 1986 Nov 27-Dec 3; 324(6095):377-80. PubMed ID: 3024013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessment of the v-fms sequence: threonine phosphorylation of the COOH-terminal domain.
    Smola U; Hennig D; Hadwiger-Fangmeier A; Schütz B; Pfaff E; Niemann H; Tamura T
    J Virol; 1991 Nov; 65(11):6181-7. PubMed ID: 1833563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements for transformation by the fms oncogene product (CSF-1 receptor).
    Rettenmier CW; Roussel MF; Wheeler EF; Sherr CJ
    Princess Takamatsu Symp; 1986; 17():211-8. PubMed ID: 2843495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of functional domains of the v-fms-encoded protein of Susan McDonough strain feline sarcoma virus by linker insertion mutagenesis.
    Lyman SD; Rohrschneider LR
    Mol Cell Biol; 1987 Sep; 7(9):3287-96. PubMed ID: 2823125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of new oncogenic forms of the murine c-fms gene.
    de Parseval N; Bordereaux D; Varlet P; Gisselbrecht S; Sola B
    J Virol; 1995 Jun; 69(6):3597-604. PubMed ID: 7745707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colony-stimulating factor-1 receptor (c-fms).
    Sherr CJ; Roussel MF; Rettenmier CW
    J Cell Biochem; 1988 Nov; 38(3):179-87. PubMed ID: 2852667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene.
    Sacca R; Stanley ER; Sherr CJ; Rettenmier CW
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3331-5. PubMed ID: 3010289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and biochemical bases for activation of the transforming potential of the proto-oncogene c-ros.
    Zong CS; Poon B; Chen J; Wang LH
    J Virol; 1993 Nov; 67(11):6453-62. PubMed ID: 8411348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic activation of v-kit involves deletion of a putative tyrosine-substrate interaction site.
    Herbst R; Munemitsu S; Ullrich A
    Oncogene; 1995 Jan; 10(2):369-79. PubMed ID: 7530827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast and hematopoietic cell transformation by the fms oncogene (CSF-1 receptor).
    Sherr CJ
    J Cell Physiol Suppl; 1987; Suppl 5():83-7. PubMed ID: 2824535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of fms-oncogene-specific tyrosine kinase activity in human leukemia cells.
    Tamura T; Brost H; Käbisch A; Lampert F; Hadwiger-Fangmeier A; Niemann H
    J Cancer Res Clin Oncol; 1989; 115(3):235-41. PubMed ID: 2526817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.